Published in Asian J Androl on December 22, 2008
A Network Biology Approach Identifies Molecular Cross-Talk between Normal Prostate Epithelial and Prostate Carcinoma Cells. PLoS Comput Biol (2016) 1.42
Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci (2012) 1.14
Molecular pathogenesis and progression of prostate cancer. Semin Oncol (2013) 1.08
Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate. Cancer Prev Res (Phila) (2011) 1.05
Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia (2009) 0.95
Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling. Biomed Res Int (2014) 0.90
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression. Transl Androl Urol (2013) 0.89
The stroma-a key regulator in prostate function and malignancy. Cancers (Basel) (2012) 0.88
Cell mates: paracrine and stromal targets for prostate cancer therapy. Nat Rev Urol (2013) 0.87
Mast cells as a potential prognostic marker in prostate cancer. Dis Markers (2013) 0.84
Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells. Prostate (2011) 0.82
Distinct function of estrogen receptor α in smooth muscle and fibroblast cells in prostate development. Mol Endocrinol (2012) 0.82
The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate. Int J Biol Sci (2014) 0.82
Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2. Br J Cancer (2016) 0.81
Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Asian J Androl (2009) 0.81
The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis. Cell Adh Migr (2016) 0.80
Immune mediators in the tumor microenvironment of prostate cancer. Chin J Cancer (2017) 0.78
The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones. Asian J Androl (2011) 0.78
Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells. Prostate (2013) 0.77
Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China. Oncotarget (2015) 0.77
TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment? J Steroid Biochem Mol Biol (2013) 0.75
Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun gene. PLoS One (2017) 0.75
The intriguing role of fibroblasts and c-Jun in the chemopreventive and therapeutic effect of finasteride on xenograft models of prostate cancer. Asian J Androl (2015) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Stromal fibroblasts in cancer initiation and progression. Nature (2004) 11.69
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res (1999) 8.63
Integrin signalling during tumour progression. Nat Rev Mol Cell Biol (2004) 6.53
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood (2005) 5.21
Role of tissue stroma in cancer cell invasion. J Pathol (2003) 4.88
Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res (2002) 3.94
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell (2005) 3.68
Tumor-stroma interactions. Curr Opin Genet Dev (2005) 2.89
Cadherin switching in human prostate cancer progression. Cancer Res (2000) 2.80
Integrins: roles in cancer development and as treatment targets. Br J Cancer (2004) 2.76
Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res (2001) 2.50
Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res (2005) 2.44
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol (2005) 2.43
Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res (2004) 2.36
Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol (1993) 2.29
Microenvironmental regulation of cancer development. Curr Opin Genet Dev (2008) 2.25
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res (2007) 2.02
The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. Cancer Res (2007) 1.99
The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer (2004) 1.86
Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells (2008) 1.78
Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res (1998) 1.74
Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem (2005) 1.73
Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst (2006) 1.70
Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal (2005) 1.65
Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Cancer Res (2006) 1.59
Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem (2006) 1.59
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate (2005) 1.56
Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation (2002) 1.47
Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc Natl Acad Sci U S A (2004) 1.45
Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer (2005) 1.42
Targeting the c-MET signaling pathway for cancer therapy. Expert Opin Investig Drugs (2008) 1.41
Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res (2006) 1.36
Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res (2001) 1.32
New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys (2002) 1.26
The role of tumor microenvironment in prostate cancer bone metastasis. J Cell Biochem (2007) 1.26
The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia (2003) 1.20
Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. Prostate (2007) 1.17
Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. Biochemistry (2007) 1.16
Prostate cancer and the met hepatocyte growth factor receptor. Adv Cancer Res (2004) 1.13
Complex cadherin expression in human prostate cancer cells. Int J Cancer (2000) 1.13
Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cancer Res (2007) 1.09
TGF-betal/Smad signaling in prostate cancer. Curr Drug Targets (2003) 1.08
The role of the stromal microenvironment in prostate cancer. Semin Cancer Biol (2004) 1.08
Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer (2006) 1.07
Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys (2007) 1.06
Androgen receptor signalling in prostate: effects of stromal factors on normal and cancer stem cells. Mol Cell Endocrinol (2008) 1.06
Can cancer cells transform normal host cells into malignant cells? Br J Cancer (1997) 1.06
CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Oncogene (2006) 1.05
A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model. Prostate (2007) 1.05
Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol (2007) 1.04
EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR). Int J Cancer (2004) 1.04
Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. Int J Cancer (1989) 1.03
Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Clin Cancer Res (2005) 1.00
Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate (2005) 1.00
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels. Prostate (2007) 1.00
Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology (1998) 0.99
Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate. Oncol Rep (2002) 0.99
Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1. Prostate (2004) 0.99
Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells. J Steroid Biochem Mol Biol (2008) 0.99
Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. Am J Pathol (2007) 0.97
Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells. Biochem Biophys Res Commun (2006) 0.97
Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells. Cancer Cell Int (2008) 0.96
Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II. Cancer Res (2008) 0.96
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost (2005) 0.93
Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Clin Exp Metastasis (2006) 0.91
Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis. Lab Invest (2007) 0.90
Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling. Endocr Relat Cancer (2005) 0.89
Under pressure: stromal fibroblasts change their ways. Cell (2005) 0.89
Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. Anticancer Res (2004) 0.87
Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Prostate (1996) 0.85
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy. Prostate (2007) 0.85
HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. Urol Oncol (2007) 0.84
cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells. Mol Carcinog (2005) 0.82
Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis. Front Biosci (2008) 0.82
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I. Int J Oncol (2007) 0.77
Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue. Asian J Androl (2011) 1.51
Androgen receptor is a potential therapeutic target for bladder cancer. Urology (2010) 0.98
Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate. Asian J Androl (2009) 0.93
The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian J Androl (2008) 0.90
Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications. Asian J Androl (2014) 0.90
Nonstented versus routine stented ureteroscopic holmium laser lithotripsy: a prospective randomized trial. Urol Res (2008) 0.90
Is it necessary and feasible to increase the efficiency of 2-µm thulium laser resection of the prostate? Asian J Androl (2013) 0.88
miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells. Med Oncol (2014) 0.88
Inguinal and subinguinal micro-varicocelectomy, the optimal surgical management of varicocele: a meta-analysis. Asian J Androl (2015) 0.85
Prenatal exposure to di-n-butyl phthalate induces anorectal malformations in male rat offspring. Toxicology (2011) 0.85
Laparoscopic radical cystectomy with extracorporeal ileal conduit urinary diversion for treatment of Chinese bladder cancer patients. Urol Int (2007) 0.84
Tubularized urethral replacement using tissue-engineered peritoneum-like tissue in a rabbit model. Urol Int (2012) 0.82
Primary stromal cells isolated from human various histological/pathological prostate have different phenotypes and tumor promotion role. Chin Med J (Engl) (2011) 0.82
Fluid-electrolyte and renal pelvic pressure changes during ureteroscopic lithotripsy. Minim Invasive Ther Allied Technol (2011) 0.80
Ureteral reconstruction using autologous tubular grafts for the management of ureteral strictures and defects: an experimental study. Urol Int (2012) 0.80
Zonal differences in prostate diseases. Chin Med J (Engl) (2012) 0.80
In vitro comparison of the vaporesection of human benign prostatic hyperplasia using 70- and 120-W 2-µm lasers. Asian J Androl (2011) 0.80
Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients. J Cancer Res Clin Oncol (2004) 0.79
Percutaneous intrarenal marsupialization of symptomatic peripelvic renal cysts: a single-centre experience in China. Scand J Urol (2012) 0.78
Stem cell-based therapy for erectile dysfunction. Chin Med J (Engl) (2011) 0.78
The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones. Asian J Androl (2011) 0.78
Differences in phenotype and gene expression of prostate stromal cells from patients of varying ages and their influence on tumour formation by prostate epithelial cells. Asian J Androl (2011) 0.78
Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer. Urology (2012) 0.78
[Surgical options for benign prostatic hyperplasia: impact on sexual function and risk factors]. Zhonghua Nan Ke Xue (2011) 0.78
Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells. Asian J Androl (2008) 0.77
Peritoneal cavity as bioreactor to grow autologous tubular urethral grafts in a rabbit model. World J Urol (2009) 0.76
Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer. Asian J Androl (2008) 0.76
Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression. Asian J Androl (2013) 0.75
Editorial and introduction to Asian Journal of Andrology Prostate Cancer special issue. Asian J Androl (2008) 0.75
[An update of biomarkers in prostate cancer tissue]. Zhonghua Nan Ke Xue (2009) 0.75
[Technique of thulium laser in managing bladder cuff in nephroureterectomy for upper urinary tract urothelium carcinoma]. Zhonghua Yi Xue Za Zhi (2012) 0.75
[Differential gene expressions in the stromal cells of the human prostate peripheral zone in males of different ages]. Zhonghua Nan Ke Xue (2012) 0.75
[Long-term efficacy of tubularized peritoneal free grafts as ureteral mucosal substitutes in dogs]. Zhonghua Yi Xue Za Zhi (2011) 0.75
Clinical relevance of heparanase mRNA expression in bladder cancer and its usefulness as a detection marker in voided urine. Mol Med Rep (2011) 0.75
The influence of ureteral stent on renal pelvic pressure in vivo. Urol Res (2009) 0.75
[Targeted degradation of androgen receptors in androgen-independent prostate cancer cells: an experimental study]. Zhonghua Nan Ke Xue (2009) 0.75
[Attach importance to Merwe disease in percutaneous nephrolithotomy]. Zhonghua Yi Xue Za Zhi (2010) 0.75
Urgent percutaneous nephrolithotomy for acute kidney injury secondary to bilateral stones: is it safe and effective in infants? World J Urol (2014) 0.75
[Two-micron laser resection of the prostate-tangerine technique for the treatment of large-volume prostate]. Zhonghua Nan Ke Xue (2014) 0.75
[Proportion of intermediate epithelial cells and human prostate cancer]. Zhonghua Nan Ke Xue (2010) 0.75
Expression of Wnt5a during development of anorectal malformations in a rat model of prenatal exposure to di(n-butyl) phthalate. Toxicol Mech Methods (2014) 0.75
[Combined treatment applied to advanced cancer of abdominal cryptorchidism (report of 12 cases)]. Zhonghua Nan Ke Xue (2006) 0.75
[Expression and implication of cyclooxygenase-2 mRNA in prostate cancer]. Zhonghua Nan Ke Xue (2006) 0.75